Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • 2000 medicines to...

    2000 medicines to become up to 90 percent cheaper: Nadda

    Written by savita thakur thakur Published On 2016-11-07T13:24:34+05:30  |  Updated On 7 Nov 2016 1:24 PM IST
    2000 medicines to become up to 90 percent cheaper: Nadda

    Union Health Minister JP Nadda has said nearly 2,000 medicines will be made available at rates up to 90 per cent less than the maximum retail price (MRP) under the Amrut Scheme.


    "Two thousand medicines will be made available at 60 to 90 percent less rates than the MRP," said the Minister on Saturday while addressing the foundation stone laying ceremony here of the proposed Super Speciality Block of Jabalpur Medical College.


    He said such retail stores would also be opened in Madhya Pradesh.


    Nadda said the central government would provide all necessary assistance to the Madhya Pradesh government to improve the state's health care facilities.


    The Minister also said the construction of the Super Specialty block, being built at a cost of Rs 150 crore, would result in provision of quality medical facilities in the state.


    He also announced setting up of a State Cancer Institute at a cost of Rs 120 crore, a trauma centre and the establishment of Central Government Health Scheme (CGHS) dispensary here.


    Madhya Pradesh Chief Minister Shivraj Singh Chouhan, who was also present on the occasion, said that after the construction of the super specialty block, the people of Jabalpur and nearby districts would not have to go outside the state for treatment.


    "To provide better health services to the people is the biggest responsibility of any government. Up to Rs 2 lakh has been entrusted to collectors under the Rajya Bimari Sahayata Scheme," Chouhan said.

    amrut schemeCentral Government Health Schemecheaper drugshealth newsHealth news IndiaJp NaddaRajya Bimari Sahayata SchemeShivraj Singh ChouhanUnion Health Minister
    Source : IANS

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok